GL1X · GenesisL1 explorer

Research workbench

Exploiting an asp-glu switch in glycogen synthase kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia

Analyse Exploiting an asp-glu switch in glycogen synthase kinase 3 to design paralog… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5T31
Type
protein
Length
669 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen synthase kinase-3 beta
EC
2.7.11.26, 2.7.11.1
UniProt
P49841
Ligands
6VL
Pockets
5 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein33536% helix, 19% strandP49841
BGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein33435% helix, 20% strandP49841

Ligands and binding sites

  • 6VL · (4~{S})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18260.670.7487empty
22820.650.81296VL
32840.620.79276VL
4500.390.8117empty
5540.370.8016empty

Interfaces

1 interface between chains.

  • A–B · 244 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.